Analytical performances of a new enzymatic assay for hemoglobin A1c.

Date publication

juillet 2014

Journal

Clinica chimica acta; international journal of clinical chemistry

Auteurs

Membres identifiés du Cancéropôle Est :
Pr GILLERY Philippe

Tous les auteurs :
Jaisson S, Desmons A, Renard B, Chevelle B, Leroy N, Gillery P

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/24768786

Résumé

HbA1c is considered the gold standard for the follow-up of diabetic patients and a new diagnostic tool for diabetes mellitus, which implies the availability of reliable assay methods. We have evaluated a new assay developed by Abbott Laboratories, based on the enzymatic quantification of HbA1c by a fructosyl dipeptide oxidase using Architect analyzers.

Mots clés

Diabetes Mellitus, blood, Enzyme Assays, methods, Hemoglobin A, Glycosylated, chemistry, Humans, Reproducibility of Results, Sensitivity and Specificity

Référence

Clin. Chim. Acta. 2014 Jul;434:48-52